+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Spain Neuromodulation Devices Market Outlook to 2033 - Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

  • PDF Icon

    Report

  • 41 Pages
  • February 2026
  • Region: Spain
  • GlobalData
  • ID: 6058736

The Spain Neuromodulation Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Neuromodulation Devices Market.
  • Global corporate-level profiles of key companies operating within the Spain Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

Spain Neuromodulation Devices is segmented as follows:

  • Implantable Neuromodulation Devices
  • Minimally Invasive Neuromodulation Devices
  • Non-Invasive Neuromodulation Devices

Reasons to Buy

The Spain Neuromodulation Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, Spain
3.1 Neuromodulation Devices Market, Spain, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, Spain, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, Spain, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, Spain, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, Spain, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, Spain, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in Spain, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 Nevro Corp
4.4.1 Company Overview
4.5 LivaNova Plc
4.5.1 Company Overview
4.6 Enterra Medical Inc
4.6.1 Company Overview
4.7 Axonics Inc
4.7.1 Company Overview
4.8 B. Braun Melsungen AG
4.8.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 04, 2025: CSIC Receives Two Technological Prototypes from CDTI for Neurological Disease Therapies
6.1.2 Sep 16, 2025: Sant Pau Integrates Hifu in New Brain Neuromodulation Unit
6.1.3 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
6.2 Government and Public Interest
6.2.1 Sep 02, 2025: Compelling Data at ESC Congress 2025 Reinforce Safety and Performance of the Medtronic Omniasecure Defibrillation Lead, Including in the Left Bundle Branch Area
6.3 Other Significant Developments
6.3.1 Nov 21, 2025: Sant Pau Incorporates Transcranial Magnetic Stimulation Device With Help From Asunción Llauradó de Febrer Foundation
6.3.2 Nov 04, 2025: CSIC Receives Two Technological Prototypes from CDTI for Neurological Disease Therapies
6.4 Product News
6.4.1 Jan 14, 2026: TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
6.4.2 Nov 21, 2025: Sant Pau Incorporates Transcranial Magnetic Stimulation Device With Help From Asunción Llauradó de Febrer Foundation
6.4.3 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
6.4.4 Oct 30, 2025: Sant Pau Incorporates MRgFUS Technology For Movement Disorders Without Surgery
6.4.5 Sep 16, 2025: Sant Pau Integrates Hifu in New Brain Neuromodulation Unit
6.4.6 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
6.5 Strategy And Business Planning
6.5.1 Nov 10, 2025: Inbrain Neuroelectronics Collaborates With Microsoft to Enhance Agentic AI for Neurology and Brain-Computer Interfaces
6.5.2 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
6.5.3 Sep 15, 2025: Inbrain Neuroelectronics Collaborates to Enhance Graphene-Based Brain-Computer Interfaces
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, Spain, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, Spain, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, Spain, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, Spain, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, Spain, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, Spain, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, Spain, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, Spain, Company Share (%), 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Enterra Medical Inc
  • Axonics Inc
  • B. Braun Melsungen AG